Bayer today unveiled version 2.5 of its Radimetrics™ Enterprise Platform at the 2014 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting. The enhanced version has new features that can help radiologists and hospital administrators meet new 2015 U.S. Joint Commission Diagnostic Imaging Standards, providing information to help optimize radiation dose management and contrast dose analytics to advance image quality and patient care.
"With billions of diagnostic imaging procedures performed every year it's essential that patients aren't exposed to unnecessary levels of radiation," said Christiane Pering, Chief Medical Officer (CMO) and Head of Innovation, Bayer Medical Care. "We recognize the urgency to not only meet the new standards coming into effect next year, but to provide technology that keeps pace with the evolving needs of radiology."
The new software is a next generation upgrade of the platform, which was the first single tool to manage both radiation dose and contrast dose analytics in computed tomography (CT). New features include more advanced contrast dose analytics and new charts and data options to help identify repeat injections and issues associated with intravenous* administration. Enhancements include the ability to align customers' various protocol names to standardized naming conventions from the RadLex® Playbook and further expand capabilities in mammography and general X-ray modalities, improving analytics and workflow efficiencies. Everything can be analyzed in line with external benchmarks, helping administrators further standardize protocols and identify training needs across all enterprise sites.
"The Radimetrics Enterprise Platform allows organizations to collect and analyze data across sites, creating large-scale, real-world dose registries that can help establish benchmarks and scanning parameters," said Dennis Durmis, Head of the Americas Region, Bayer's Radiology business. "We're now seeing how these data may help improve protocols, with registry information being presented at international scientific symposia."
The use of radiation in medicine has led to vast improvements in the diagnosis and treatment of diseases and patient care. Each year, there are more than 3.5 billion X-ray examinations performed worldwide and more than 85 million CT examinations performed in the U.S. Health authorities and policy makers, such as the U.S. Joint Commission, are increasingly evaluating the risk-benefit profile of patient exposure to ionizing radiation.
Precision medicine in PET imaging: AI-based attenuation correction for enhanced patient care